ACRUS broadens contraceptive spray strategy

Acrux (ASX: ACR), the Australian company with patient-preferred technology for delivering drugs across the skin, today announced that it has reached agreement with Population Council, Inc., to amend the Licence Agreement signed in February 2006.

Under the Licence Agreement, Acrux is developing a contraceptive spray, combining Acrux's patented MDTS spray delivery technology with Population Council's new generation contraceptive Nestorone. Established in 1952 and headquartered in New York, Population Council has a proven track record in the successful development of female contraceptive products.

Under the terms of the amendment, Acrux is no longer restricted to developing and commercialising only contraceptive sprays containing Nestorone. All other material terms of the Licence Agreement remain unchanged.

"This amendment has paved the way for Acrux to apply MDTS to a far wider range of contraceptive hormones, which in turn makes our technology more attractive to potential global partners," said Richard Treagus, Acrux CEO.

Following the successful completion of Phase 1 clinical trials with Nestorone MDTS, Acrux has moved quickly to start formulation development of additional contraceptive spray products.

"The global market for hormonal contraceptives approximates US$6.5 billion per annum. With the MDTS technology applicable to a range of contraceptive hormones, it was important to ensure that we were in the strongest possible position to fully exploit the value of our technology in this market", Treagus added.

MDTS has a number of advantages over existing methods of contraceptive delivery systems, such as pills and patches. At launch, the contraceptive MDTS will be the first transdermal contraceptive spray in the market, and it has the potential to become the contraceptive of choice for many women.


Contact: Richard Treagus
Research Australia

Page: 1

Related biology news :

1. Species thrive when sexual dimorphism broadens their niches
2. Implanon, Norplant and Jadelle are all effective contraceptives -- but side effects vary
3. New research finds that a natural family planning method is as effective as the contraceptive pill
4. Lack of GBA2: A contraceptive for male mice
5. Male contraceptive study expands to 4 US cities
6. New male contraceptive targets sperm, not hormones
7. New male contraceptive clears hurdle
8. Of mice and mens (and womens) contraceptives
9. Global study concludes attack rate of flu in kids is 55 percent lower with nasal spray vaccine
10. Harvard team creates spray drying technique for TB vaccine
11. Flu shot effective against drifted influenza, nasal spray vaccine less so

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: